Skip to content

Trident® X3 Polyethylene Insert Study

An Open-label, Prospective, Post-market, Historically Controlled, Multi-center Clinical Evaluation of the Trident® X3 Polyethylene Acetabular Inserts.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00958191
Enrollment
250
Registered
2009-08-13
Start date
2005-05-31
Completion date
2016-12-31
Last updated
2018-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthroplasty, Replacement, Hip

Brief summary

The primary objective of the study is to demonstrate the linear wear rates of the Trident® X3 polyethylene insert are superior to a polyethylene control group wear rate at 5 years postoperative. This measurement will be evaluated by comparing digitized images of serial radiographs obtained over a follow-up period of 5-years.

Detailed description

The study is a prospective, multi-center, historical-controlled clinical evaluation of the Trident® X3 Polyethylene insert. The device is commercially available in the United States where the study is being conducted. The study device, the Stryker Orthopaedics Trident® X3 polyethylene insert, is used for the replacement of the bearing surface of the acetabulum to relieve pain, instability, and the restriction of motion due to degenerative bone disease, including osteoarthritis, rheumatoid arthritis, trauma, or failure of other devices. The control device, the Stryker Orthopaedics N2VAC polyethylene insert, is also used for the replacement of the bearing surface of the acetabulum to relieve pain, instability, and the restriction of motion due to degenerative bone disease, including osteoarthritis, rheumatoid arthritis, trauma, or failure of other devices.

Interventions

DEVICETrident® X3 Polyethylene Insert

Trident® X3 Polyethylene Insert

Sponsors

Stryker Orthopaedics
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. The patient has signed an IRB-approved, study specific Patient Informed Consent Form. 2. The patient is a candidate for a primary total hip replacement with cementless acetabular and femoral components. 3. The patient has a primary diagnosis of Non-Inflammatory Degenerative Joint Disease (NIDJD). Patient must have diagnosis of osteoarthritis (OA), traumatic arthritis (TA), avascular necrosis (AVN), slipped capital epiphysis, pelvic fracture, femoral fracture, failed fracture fixation, or diastrophic variant. 4. The patient is a male or non-pregnant female patient ages 21 to 75. 5. The patient is willing and able to comply with postoperative scheduled clinical and radiographic evaluations and rehabilitation.

Exclusion criteria

1. The patient has an active infection with the affected hip joint. 2. The patient requires revision surgery of a previously implanted total hip arthroplasty or hip fusion to the affected joint. 3. The patient has a BMI \>45. 4. The patient has a neuromuscular or neurosensory deficiency, which limits ability to evaluate the safety and efficacy of the device. 5. The patient has diagnosed systemic disease (i.e. Paget's disease, renal osteodystrophy). 6. The patient is immunologically suppressed or receiving chronic steroids in excess of 5mg per day. 7. The patient has a recent history of substance dependency that may result in deviations from the evaluation schedule. 8. The patient is a prisoner.

Design outcomes

Primary

MeasureTime frameDescription
Mean Linear Wear Rate at 5 Years5 yearsLinear wear rates are defined as the annual rate of removal of the polyethylene from the polyethylene insert determined by comparing digitized images of serial radiographs obtained over the follow-up period of 5 years
Rate of Incidence of Revision of Component for Any Reason5 yearRevision of any component is defined as surgical removal and replacement of the femoral component, acetabular shell, acetabular insert and/or femoral head.

Secondary

MeasureTime frameDescription
Radiographic Stability1,2,3,4 and 5 yearsRadiographic stability is defined as having all of the following: no radiographic indication of progressive radiolucent lines greater than or equal to 2 mm around the entire acetabular cup, no radiographic indication of acetabular cup migration of greater than or equal to 3 mm, no radiographic indication of progressive radiolucent lines greater than or equal to 2 mm around the entire femoral component, and no radiographic indication of progressive subsidence of the femoral component of greater than or equal to 5 mm. Radiographs are evaluated at 1,2,3,4 and 5 years.
Mean Harris Hip Score (HHS) to Assess Changepre-operative, 1,3 and 5 yearsThe change in HHS is reported by comparing the mean preoperative, 1, 3 and 5 year postoperative scores that assess pain, function, joint deformity and range of motion. Scores can range from 0 to 100 with 0 being the worst and 100 being the best score. A score of 80-100 is considered good-excellent and a score less than or equal to 79 is considered fair-poor. 90 - 100 = excellent 80 - 89 = good 70 - 79 = fair 0 - 69 = poor
Mean Harris Hip Score (HHS) Pain Score to Assess Changepre-operative, 1,3, and 5 yearsThe change in HHS Pain is reported by comparing the mean preoperative, 1, 3 and 5 year postoperative pain scores. Scores can range from 0 to 44, with 0 indicating totally disabling pain and 44 indicating no pain or pain that is ignored. * None or ignores it = 44 points * Slight, occasional, no compromise in activities = 40 points * Mild pain, no effect on average activities, rarely moderate pain with unusual activity;may take aspirin = 30 points * Moderate pain, tolerable, but makes concessions to pain. Some limitation of ordinary activity or work. May require occasional pain medication stronger than aspirin = 20 points * Marked pain, serious limitation of activites = 10 points * Totally disabled, crippled, pain in bed, bedridden = 0 points
Linear Wear Rate of the Trident X3 Polyethylene Insert2, 3 and 4 year films collected; 3 and 4 year wear assessedLinear wear rates are defined as the annual rate of removal of the polyethylene from the polyethylene insert determined by comparing digitized images of serial radiographs obtained over the follow-up period. NOTE: 2 year linear and volumetric wear was not calculated for the following reason: To determine polyethylene wear, the total femoral head penetration is first calculated from the radiographs.The femoral head penetration has two components namely wear and creep (or bedding-in). It is not possible to separate the total penetration in to two components. The creep of the polyethylene starts from the date of surgery and continues up to 12-24 months. Therefore, the head penetration value at 2-years is dominated by Creep rather than wear.
Mean SF-12 Health Survey Score to Assess Changepre-operative, 1,3 and 5 yearsChange in the SF-12 score is reported by comparing the mean preoperative, 1,3 and 5 year postoperative scores.The SF-12 Health Survey is a 12-item patient completed questionnaire to measure general health and well-being. It includes a physical and mental status component score; each ranging from 0-100. Low values represent a poor health state and high values represent a good health state.
Mean Lower Extremity Activity Scale (LEAS) Score to Assess Changepre-operative, 1,3 and 5 yearsChange in the LEAS is reported by comparing the mean preoperative, 1,3 and 5 year scores. The LEAS is completed by the participant to assess activity level. Activity levels are ordered in terms of intensity from 1 to 18, with 18 indicating the highest activity level.
Implant Survivorship10 yearsImplant survivorship is determined using the Kaplan-Meier method.
Mean Harris Hip Score (HHS) Range of Motion (ROM) Score to Assess Changepre-operative, 1,3 and 5 yearsThe change in HHS ROM is reported by comparing the mean preoperative, 1, 3 and 5 year postoperative scores. Scores can range from 0 (worst) to 5 (best). The degrees of motion are measured for hip flexion, abduction, adduction, external rotation and internal rotation. The measured values are added to determine a combined value that is associated with a score from 0 to 5. * 211-300 degrees = 5 points * 161 to 210 degrees = 4 points * 101 to 160 degrees = 3 points * 61 to 100 degrees = 2 points * 31 to 60 degrees = 1 points * 0 to 30 degrees = 0 points
Volumetric Wear Rate of the Trident X3 Polyethylene Insert2, 3, 4 and 5 year films collected; 3, 4 and 5 year wear assessedVolumetric wear rate is calculated using a formula based on the cylindrical wear pattern perpendicular to the face of the cup and the mean linear wear rate. NOTE: 2 year linear and volumetric wear was not calculated for the following reason: To determine polyethylene wear, the total femoral head penetration is first calculated from the radiographs.The femoral head penetration has two components namely wear and creep (or bedding-in). It is not possible to separate the total penetration in to two components. The creep of the polyethylene starts from the date of surgery and continues up to 12-24 months. Therefore, the head penetration value at 2-years is dominated by Creep rather than wear.

Countries

United States

Participant flow

Recruitment details

For bilateral hip replacement participants, if one hip completed primary endpoint #1 the participant is counted as completed. If one hip was censored, but the other hip was not, the hip is counted as censored, but the participant is not.

Pre-assignment details

250 participants/271 hips enrolled - 29 participants/31 hips censored= 221 participants/240 hips followed. There were 5 revisions, but one bilateral participant had one hip revised and the other hip completed the primary endpoint. This participant is counted as completed and not in the revision category.

Participants by arm

ArmCount
Trident® X3 Polyethylene Insert
All subjects who recieved the Trident X3 insert.
221
Total221

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyDeath4
Overall StudyInadequate 5 yr x-ray quality10
Overall StudyLost to Follow-up5
Overall StudyNo 5 yr x-rays56
Overall StudyRevision of study device4
Overall StudySite termination11
Overall StudyUnable/Unwilling to Return/Withdrawal21

Baseline characteristics

CharacteristicTrident® X3 Polyethylene Insert
Age, Continuous62.04 years
STANDARD_DEVIATION 8.74
Region of Enrollment
United States
221 Participants
Sex: Female, Male
Female
116 Participants
Sex: Female, Male
Male
105 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
62 / 24065 / 221
serious
Total, serious adverse events
12 / 24033 / 221

Outcome results

Primary

Mean Linear Wear Rate at 5 Years

Linear wear rates are defined as the annual rate of removal of the polyethylene from the polyethylene insert determined by comparing digitized images of serial radiographs obtained over the follow-up period of 5 years

Time frame: 5 years

ArmMeasureValue (MEAN)Dispersion
Trident® X3 Polyethylene InsertMean Linear Wear Rate at 5 Years0.016 mm/yearStandard Deviation 0.068
Primary

Rate of Incidence of Revision of Component for Any Reason

Revision of any component is defined as surgical removal and replacement of the femoral component, acetabular shell, acetabular insert and/or femoral head.

Time frame: 5 year

Population: Difference of 5 participants from the participant flow completed (=110): 4 participants are included in the revision category of the participant flow and one participant had revision of only the femoral head \& stem but later withdrew from the study \& is included in the withdrawal category of the participant flow.

ArmMeasureValue (NUMBER)
Trident® X3 Polyethylene InsertRate of Incidence of Revision of Component for Any Reason4.84 percentage of hips undergoing revision
Secondary

Implant Survivorship

Implant survivorship is determined using the Kaplan-Meier method.

Time frame: 10 years

Population: Participants with available data. The population includes all 240 cases who were initially consented to 5 year study.~There are 127 cases who consented to continue in the 10 year study.

ArmMeasureGroupValue (NUMBER)
Trident® X3 Polyethylene InsertImplant SurvivorshipKaplan-Meier Estimate (based on 10 year cases)98.37 percentage of hips
Trident® X3 Polyethylene InsertImplant SurvivorshipKaplan-Meier Estimate (based on 5 year cases)95.79 percentage of hips
Secondary

Linear Wear Rate of the Trident X3 Polyethylene Insert

Linear wear rates are defined as the annual rate of removal of the polyethylene from the polyethylene insert determined by comparing digitized images of serial radiographs obtained over the follow-up period. NOTE: 2 year linear and volumetric wear was not calculated for the following reason: To determine polyethylene wear, the total femoral head penetration is first calculated from the radiographs.The femoral head penetration has two components namely wear and creep (or bedding-in). It is not possible to separate the total penetration in to two components. The creep of the polyethylene starts from the date of surgery and continues up to 12-24 months. Therefore, the head penetration value at 2-years is dominated by Creep rather than wear.

Time frame: 2, 3 and 4 year films collected; 3 and 4 year wear assessed

Population: Participants/hips with available data. Overall number of participants and units analyzed is based upon the 3 year population.

ArmMeasureGroupValue (MEAN)Dispersion
Trident® X3 Polyethylene InsertLinear Wear Rate of the Trident X3 Polyethylene Insert3 year mean wear rate0.022 mm/yearStandard Deviation 0.133
Trident® X3 Polyethylene InsertLinear Wear Rate of the Trident X3 Polyethylene Insert4 year mean wear rate0.024 mm/yearStandard Deviation 0.087
Secondary

Mean Harris Hip Score (HHS) Pain Score to Assess Change

The change in HHS Pain is reported by comparing the mean preoperative, 1, 3 and 5 year postoperative pain scores. Scores can range from 0 to 44, with 0 indicating totally disabling pain and 44 indicating no pain or pain that is ignored. * None or ignores it = 44 points * Slight, occasional, no compromise in activities = 40 points * Mild pain, no effect on average activities, rarely moderate pain with unusual activity;may take aspirin = 30 points * Moderate pain, tolerable, but makes concessions to pain. Some limitation of ordinary activity or work. May require occasional pain medication stronger than aspirin = 20 points * Marked pain, serious limitation of activites = 10 points * Totally disabled, crippled, pain in bed, bedridden = 0 points

Time frame: pre-operative, 1,3, and 5 years

Population: Participants/hips with available data. Overall number of participants and units analyzed is based upon the preoperative population.

ArmMeasureGroupValue (MEAN)Dispersion
Trident® X3 Polyethylene InsertMean Harris Hip Score (HHS) Pain Score to Assess ChangeHHS Pain Mean Preoperative Score16.73 units on a scaleStandard Deviation 8.24
Trident® X3 Polyethylene InsertMean Harris Hip Score (HHS) Pain Score to Assess ChangeHHS Pain Mean 1 Year Score41.52 units on a scaleStandard Deviation 5.64
Trident® X3 Polyethylene InsertMean Harris Hip Score (HHS) Pain Score to Assess ChangeHHS Pain Mean 3 Year Score42.50 units on a scaleStandard Deviation 4.89
Trident® X3 Polyethylene InsertMean Harris Hip Score (HHS) Pain Score to Assess ChangeHHS Pain Mean 5 Year Score41.75 units on a scaleStandard Deviation 5.99
Comparison: Change in Harris Hip Pain Score from pre-op to 1 yearp-value: <0.0001Sign test
Comparison: Change in Harris Hip Pain Score from pre-op to 3 yearsp-value: <0.0001Sign test
Comparison: Change in Harris Hip Pain Score from pre-op to 5 yearsp-value: <0.0001Sign test
Secondary

Mean Harris Hip Score (HHS) Range of Motion (ROM) Score to Assess Change

The change in HHS ROM is reported by comparing the mean preoperative, 1, 3 and 5 year postoperative scores. Scores can range from 0 (worst) to 5 (best). The degrees of motion are measured for hip flexion, abduction, adduction, external rotation and internal rotation. The measured values are added to determine a combined value that is associated with a score from 0 to 5. * 211-300 degrees = 5 points * 161 to 210 degrees = 4 points * 101 to 160 degrees = 3 points * 61 to 100 degrees = 2 points * 31 to 60 degrees = 1 points * 0 to 30 degrees = 0 points

Time frame: pre-operative, 1,3 and 5 years

Population: Participants/hips with available data. Overall number of participants and units analyzed is based upon the preoperative population.

ArmMeasureGroupValue (MEAN)Dispersion
Trident® X3 Polyethylene InsertMean Harris Hip Score (HHS) Range of Motion (ROM) Score to Assess ChangeHHS ROM Mean Preoperative Score3.90 units on a scaleStandard Deviation 0.95
Trident® X3 Polyethylene InsertMean Harris Hip Score (HHS) Range of Motion (ROM) Score to Assess ChangeHHS ROM Mean 1 Year Score4.99 units on a scaleStandard Deviation 0.12
Trident® X3 Polyethylene InsertMean Harris Hip Score (HHS) Range of Motion (ROM) Score to Assess ChangeHHS ROM Mean 3 Year Score4.99 units on a scaleStandard Deviation 0.11
Trident® X3 Polyethylene InsertMean Harris Hip Score (HHS) Range of Motion (ROM) Score to Assess ChangeHHS ROM Mean 5 Year Score4.93 units on a scaleStandard Deviation 0.31
Comparison: Change in Harris Hip ROM score from pre-op to 1 yearp-value: <0.0001Sign test
Comparison: Change in Harris Hip ROM score from pre-op to 3 yearsp-value: <0.0001Sign test
Comparison: Change in Harris Hip ROM score from pre-op to 5 yearsp-value: <0.0001Sign test
Secondary

Mean Harris Hip Score (HHS) to Assess Change

The change in HHS is reported by comparing the mean preoperative, 1, 3 and 5 year postoperative scores that assess pain, function, joint deformity and range of motion. Scores can range from 0 to 100 with 0 being the worst and 100 being the best score. A score of 80-100 is considered good-excellent and a score less than or equal to 79 is considered fair-poor. 90 - 100 = excellent 80 - 89 = good 70 - 79 = fair 0 - 69 = poor

Time frame: pre-operative, 1,3 and 5 years

Population: Participants/hips with available data. Overall number of participants and units analyzed is based upon the preoperative population.

ArmMeasureGroupValue (MEAN)Dispersion
Trident® X3 Polyethylene InsertMean Harris Hip Score (HHS) to Assess ChangeHHS Mean 1 Year Score94.41 units on a scaleStandard Deviation 8.75
Trident® X3 Polyethylene InsertMean Harris Hip Score (HHS) to Assess ChangeHHS Mean 3 Year Score95.32 units on a scaleStandard Deviation 8.32
Trident® X3 Polyethylene InsertMean Harris Hip Score (HHS) to Assess ChangeHHS Mean 5 year Score94.05 units on a scaleStandard Deviation 8.7
Trident® X3 Polyethylene InsertMean Harris Hip Score (HHS) to Assess ChangeHHS Mean Preoperative Score53.01 units on a scaleStandard Deviation 13.68
Comparison: Change in HHS from pre-op to 1 yearp-value: <0.0001Sign test
Comparison: Change in HHS from pre-op to 3 yearsp-value: <0.0001Sign test
Comparison: Change in HHS from pre-op to 5 yearsp-value: <0.0001t-test, 2 sided
Secondary

Mean Lower Extremity Activity Scale (LEAS) Score to Assess Change

Change in the LEAS is reported by comparing the mean preoperative, 1,3 and 5 year scores. The LEAS is completed by the participant to assess activity level. Activity levels are ordered in terms of intensity from 1 to 18, with 18 indicating the highest activity level.

Time frame: pre-operative, 1,3 and 5 years

Population: Participants/hips with available data. Overall number of participants and units analyzed is based upon the preoperative population.

ArmMeasureGroupValue (MEAN)Dispersion
Trident® X3 Polyethylene InsertMean Lower Extremity Activity Scale (LEAS) Score to Assess ChangeMean LEAS score Preoperative8.95 units on a scaleStandard Deviation 2.54
Trident® X3 Polyethylene InsertMean Lower Extremity Activity Scale (LEAS) Score to Assess ChangeMean LEAS score 1 year11.65 units on a scaleStandard Deviation 3.01
Trident® X3 Polyethylene InsertMean Lower Extremity Activity Scale (LEAS) Score to Assess ChangeMean LEAS score 3 years11.69 units on a scaleStandard Deviation 2.95
Trident® X3 Polyethylene InsertMean Lower Extremity Activity Scale (LEAS) Score to Assess ChangeMean LEAS score 5 years10.92 units on a scaleStandard Deviation 2.92
Comparison: Change in LEAS Score from preop to 1 yearp-value: <0.0001Sign test
Comparison: Change in LEAS Score from preop to 3 yearp-value: <0.0001Sign test
Comparison: Change in LEAS Score from preop to 5 yearp-value: <0.0001t-test, 2 sided
Secondary

Mean SF-12 Health Survey Score to Assess Change

Change in the SF-12 score is reported by comparing the mean preoperative, 1,3 and 5 year postoperative scores.The SF-12 Health Survey is a 12-item patient completed questionnaire to measure general health and well-being. It includes a physical and mental status component score; each ranging from 0-100. Low values represent a poor health state and high values represent a good health state.

Time frame: pre-operative, 1,3 and 5 years

Population: Participants/hips with available data. Overall number of participants and units analyzed is based upon the preoperative population.

ArmMeasureGroupValue (MEAN)Dispersion
Trident® X3 Polyethylene InsertMean SF-12 Health Survey Score to Assess ChangeMean SF-12 Physical Score Preoperative32.11 units on a scaleStandard Deviation 8.86
Trident® X3 Polyethylene InsertMean SF-12 Health Survey Score to Assess ChangeMean SF-12 Physical Score 1 year49.90 units on a scaleStandard Deviation 8.51
Trident® X3 Polyethylene InsertMean SF-12 Health Survey Score to Assess ChangeMean SF-12 Physical Score 3 years49.97 units on a scaleStandard Deviation 8.74
Trident® X3 Polyethylene InsertMean SF-12 Health Survey Score to Assess ChangeMean SF-12 Physical Score 5 years49.08 units on a scaleStandard Deviation 8.38
Trident® X3 Polyethylene InsertMean SF-12 Health Survey Score to Assess ChangeMean SF-12 Mental Score Preoperative53.75 units on a scaleStandard Deviation 10.91
Trident® X3 Polyethylene InsertMean SF-12 Health Survey Score to Assess ChangeMean SF-12 Mental Score 1 year55.72 units on a scaleStandard Deviation 7.83
Trident® X3 Polyethylene InsertMean SF-12 Health Survey Score to Assess ChangeMean SF-12 Mental Score 3 years55.78 units on a scaleStandard Deviation 8.13
Trident® X3 Polyethylene InsertMean SF-12 Health Survey Score to Assess ChangeMean SF-12 Mental Score 5 years54.88 units on a scaleStandard Deviation 7.76
Comparison: Change in SF-12 Phyiscal Component Score from preop to 1 yearp-value: <0.0001Sign test
Comparison: Change in SF-12 Phyiscal Component Score from preop to 3 yearp-value: <0.0001t-test, 2 sided
Comparison: Change in SF-12 Phyiscal Component Score from preop to 5 yearp-value: <0.0001Sign test
Comparison: Change in SF-12 Mental Component Score from preop to 1 yearp-value: 0.0242Sign test
Comparison: Change in SF-12 Mental Component Score from preop to 3 yearp-value: 0.0247Sign test
Comparison: Change in SF-12 Mental Component Score from preop to 5 yearp-value: 0.1372Sign test
Secondary

Radiographic Stability

Radiographic stability is defined as having all of the following: no radiographic indication of progressive radiolucent lines greater than or equal to 2 mm around the entire acetabular cup, no radiographic indication of acetabular cup migration of greater than or equal to 3 mm, no radiographic indication of progressive radiolucent lines greater than or equal to 2 mm around the entire femoral component, and no radiographic indication of progressive subsidence of the femoral component of greater than or equal to 5 mm. Radiographs are evaluated at 1,2,3,4 and 5 years.

Time frame: 1,2,3,4 and 5 years

Population: Participants/hips with available data. Overall number of participants and units analyzed is based upon the 1 year population.

ArmMeasureGroupValue (NUMBER)
Trident® X3 Polyethylene InsertRadiographic StabilityRadiographically unstable at 1 year0 hips evaluated as unstable on radiograph
Trident® X3 Polyethylene InsertRadiographic StabilityRadiographically unstable at 2 years0 hips evaluated as unstable on radiograph
Trident® X3 Polyethylene InsertRadiographic StabilityRadiographically unstable at 3 years0 hips evaluated as unstable on radiograph
Trident® X3 Polyethylene InsertRadiographic StabilityRadiographically unstable at 4 years0 hips evaluated as unstable on radiograph
Trident® X3 Polyethylene InsertRadiographic StabilityRadiographically unstable at 5 years0 hips evaluated as unstable on radiograph
Secondary

Volumetric Wear Rate of the Trident X3 Polyethylene Insert

Volumetric wear rate is calculated using a formula based on the cylindrical wear pattern perpendicular to the face of the cup and the mean linear wear rate. NOTE: 2 year linear and volumetric wear was not calculated for the following reason: To determine polyethylene wear, the total femoral head penetration is first calculated from the radiographs.The femoral head penetration has two components namely wear and creep (or bedding-in). It is not possible to separate the total penetration in to two components. The creep of the polyethylene starts from the date of surgery and continues up to 12-24 months. Therefore, the head penetration value at 2-years is dominated by Creep rather than wear.

Time frame: 2, 3, 4 and 5 year films collected; 3, 4 and 5 year wear assessed

Population: Participants/hips with available data. Overall number of participants and units analyzed is based upon the 3 year population.

ArmMeasureGroupValue (NUMBER)
Trident® X3 Polyethylene InsertVolumetric Wear Rate of the Trident X3 Polyethylene Insert3 year volumetric wear rate17.9 cubic mm/year
Trident® X3 Polyethylene InsertVolumetric Wear Rate of the Trident X3 Polyethylene Insert4 year volumetric wear rate19.1 cubic mm/year
Trident® X3 Polyethylene InsertVolumetric Wear Rate of the Trident X3 Polyethylene Insert5 year volumetric wear rate13.3 cubic mm/year

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026